Medicare began covering certain GLP-1 weight loss drugs on July 1, 2026, giving millions of eligible beneficiaries access to ...

The Trump administration is proposing a new rule to keep hospitals from marking up discounted drugs for Medicare patients.

GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is ...

The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...

The Trump administration will launch its pilot program on Wednesday. It lasts 18 months, and estimated costs to taxpayers ...

Medicare’s new GLP-1 bridge program will provide eligible Part D prescription plan enrollees inexpensive monthly copays for ...

As Medicare continues to evolve, 2026 brings another round of important updates to Medicare Part D that could affect ...

Medicare drug plan changes in 2026 may raise your prescription costs. Here is what beneficiaries need to know about ...

As anti-obesity drugs Wegovy (semaglutide) and Mounjaro (tirzepatide) will be reimbursed as of Monday, June 15, the secretaries of the specialized obesity center (CSO) at the Pitié-Salpêtrière ...

For stories on healthy living, subscribe to NPR's Health newsletter. Every time David Davis talks to a nurse at Vida Health, he thinks he'll finally get the OK for Zepbound. And every time so far he ...

A blanket refusal to cover weight-loss medication like GLP-1s is no longer allowed under Washington state law, an appeals court ruled last week. Many health insurances do not provide coverage to ...